LOLISTREL CONTINU 100 micrograms/20 micrograms, coated tablet 63 tablets
Active ingredients: Levonorgestrel, Ethinylestradiol
Commercialized according to BDPMDispensing in France: Prescription only
Coated tablet63 tabletsorale
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- LOLISTREL CONTINU 100 microgrammes/20 microgrammes, comprimé enrobé
- Pharmaceutical form
- comprimé enrobé et comprimé enrobé
- Route of administration
- orale
- Presentation description
- 3 plaquettes PVC PVDC aluminium de 21 comprimés actifs et 7 comprimés placebo
- Marketing authorisation holder
- EXELTIS SANTE
- Reimbursement according to BDPM
- 65%
- Approval for use in healthcare institutions
- non
- Commercialization declaration date
- 4 Jan 2024
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
64099785CIP73014057CIP133400930140574Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| LÉVONORGESTRELcomprimé actif (rose) | 100 microgrammes · un comprimé | SA |
| ÉTHINYLESTRADIOLcomprimé actif (rose) | 20 microgrammes · un comprimé | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.